RF Safe has been sounding the alarm for decades: wireless radiation is not “safe” just because industry-funded studies and captured regulators say so. The Danish mobile phone cohort study (Frei et al., 2011) was a cornerstone of the “no risk” narrative for over a decade. It claimed no increased brain tumor risk from mobile phones. But as Lennart Hardell and Mona Nilsson exposed in their bombshell May 2026 paper in Archives of Internal Medicine Research, that study was corrupted from the beginning by design flaws, massive exposure misclassification, and telecom industry ties.
The real science—high-certainty animal evidence, rising U.S. cancer rates, failed regulatory limits, and major 2025–2026 policy shifts—is now crystal clear. The Danish study propped up a false narrative of safety while actual risks to cancer, fertility, and pregnancy were buried. This report updates our previous analysis with the latest evidence, including 2025 WHO-commissioned reviews showing high certainty of harm in animals, the Melnick/Moskowitz 2026 paper exposing limits that are hundreds of times too high, skyrocketing U.S. tumor rates, FDA walk-backs, U.S. withdrawal from WHO, and ongoing FCC legal defeats.
The Danish cohort didn’t just have “flaws”—it was engineered to find nothing. And the house of cards is collapsing.
1. The Danish Cohort Study: Corrupted from the Start
Published in the British Medical Journal in 2011, the study followed ~358,000 private mobile subscribers (1987–1995) and compared them to the “rest of the population” as unexposed. Conclusion: no brain tumor risk. It was hailed as gold-standard evidence and heavily weighted in international reviews.
But Hardell and Nilsson’s 2026 analysis proves it was fatally flawed and biased from inception:
- Telecom funding and design bias: Partially funded by Danish telecom operators. The study deliberately excluded the heaviest users—over 200,000 corporate subscribers (1982–1995)—and dumped them into the “unexposed” control group. Swedish data showed these users averaged 5 times more monthly airtime. This was not an oversight; it was structural corruption of exposure assessment.
- Massive misclassification: Another 164,000+ subscribers were excluded. Post-1995 users (the explosion of adoption) contaminated the control group. By 2005, Denmark had 100 subscriptions per 100 people.
- No real exposure data: “Exposure” was just years since first private subscription. No call time, no laterality, no cordless phones, no actual usage. Heavy and light users were averaged together.
- Result: Impossible to compare truly exposed vs. unexposed or detect dose-response. IARC called it “uninformative” in 2011 for exactly these reasons. It couldn’t possibly detect cancer risks.
This wasn’t science—it was a shield for the industry. The study was corrupted from the beginning to deliver the null result regulators and telecom giants needed.
2. Danish Cancer Statistics Directly Contradict the Study
The authors claimed stable Nordic trends supported “no risk.” Wrong. Denmark-specific data (the only relevant comparator) show clear increases in CNS/brain tumors:
- Cases nearly doubled from 827 (1990) to 1,807 (2015), with continued rises through 2023.
- Accelerated increases from ~2004, steeper post-2014 (both sexes).
- Age-standardized rates (Nordic 2000) rose sharply—Denmark had the largest increase among Nordics.
Aggregated Nordic data hid this because Sweden’s registry underreports and other countries varied. The Danish cohort’s null findings are directly contradicted by the very population it studied.
3. Over-Weighted in WHO 2024 Despite Being Junk Science
The 2024 WHO systematic review (Karipidis et al.) gave the Danish study high weight and “low risk of bias”—even as it downplayed stronger case-control studies (Interphone, Hardell). Hardell/Nilsson’s critiques (2025 and 2026) exposed the bias: ICNIRP overlaps among authors, unequal standards, and ignoring highest-exposure data. ICNIRP’s thermal-only limits would collapse if cancer risks were acknowledged.
4. The Real Science That Was Suppressed: 2025–2026 Breakthroughs
While the Danish study misled policymakers, the evidence of harm piled up:
- High-certainty animal evidence (2025 WHO reviews): Systematic reviews commissioned by WHO concluded high certainty that RF-EMF causes cancer (gliomas, heart schwannomas) and reproductive/pregnancy harm in animals. These match human tumor types from Interphone/Hardell. NTP (2018) and Ramazzini findings are now undeniable.
- Melnick & Moskowitz 2026 (Environmental Health): Using NTP data and gold-standard EPA risk assessment methods (1 in 100,000 excess cancer risk), current FCC/ICNIRP limits (0.08 W/kg) are 15- to 900-fold too high for cancer protection (depending on daily exposure hours). For male fertility/reproductive toxicity, limits are 8- to 24-fold too high. Cell phones and wireless networks fail to protect us—by orders of magnitude.
- U.S. cancer incidence exploding (Moskowitz/SEER analysis, 2026 update): National Cancer Institute SEER 21 data (covering ~48% of U.S. population) show:
- Thyroid cancer doubled (7.65 to 15.35 per 100,000, 2000–2023), with recent 5.1% annual rise.
- Meningioma (most common brain tumor) rising sharply.
- Glioblastoma increases in young adults and elderly.
- Salivary gland and other head/neck tumors up. These are exactly the tumors linked to RF exposure in human and animal studies. Over-diagnosis doesn’t explain it all—wireless proliferation does.
5. U.S. Regulatory Collapse in 2025–2026
- U.S. withdrawal from WHO (January 2026): Formal exit due to governance failures, lack of independence, and accountability issues. WHO’s reliance on ICNIRP is part of the problem.
- FDA walk-back: Removed webpages claiming cellphone radiation is safe. HHS (under RFK Jr./MAHA) launched a new study on electromagnetic radiation health effects.
- FCC lawsuit disaster: Lost the landmark 2021 case (EHT/CHD v. FCC) for ignoring non-thermal effects, children, long-term exposure, and the environment. FCC remains non-compliant on remand.
- Children’s Health Defense Fund action (May 2026): Filed Writ of Mandamus to force FCC compliance within 90 days. The agency can’t keep stonewalling.
Regulatory capture is ending. The Danish study’s “safety” myth helped delay action for 15 years.
6. What This Means: The Danish Study Was the Linchpin of a Failed Safety Narrative
The Danish cohort wasn’t just flawed—it was weaponized to dismiss risks while real evidence (case-control studies showing heavy-use risks, animal tumors, now high-certainty reviews, incidence spikes, and exposure limits that are hundreds of times too lax) accumulated. Industry influence, selective exclusions, and captured evaluations delayed protection.
RF Safe has always said: Distance is your best friend. Wired alternatives, shielding, hands-free, and reduced exposure (especially for kids) are non-negotiable. 5G densification without updated limits is reckless.
Call to Action
The science is no longer debatable. The Danish study was corrupted science that protected industry profits over public health. With high-certainty animal data, failing limits (per EPA standards), rising cancers, and U.S. agencies finally acknowledging gaps, the time for precaution is now.
- Demand FCC/ICNIRP limits be slashed based on Melnick/Moskowitz analysis.
- Support independent research and lawsuits (CHD, EHT).
- Choose safer tech: reduce wireless, use wired, shield where possible.
- Protect children—latency means their risks are highest.
RF Safe will keep fighting until wireless is made safe. The Danish cohort is dead. Real protection is overdue.
Key Sources: Hardell & Nilsson (2026); Melnick & Moskowitz (2026); Mevissen et al. (2025 WHO review); SEER 21 data (Moskowitz analysis); FDA/HHS statements (2026); CHD v. FCC filings.